What about incorporating selenium in the therapeutic regimen of SARS-CoV-2?

Authors

  • Bachir Benarba Laboratory Research on Biological Systems and Geomatics, Faculty of Nature and Life Sciences, University of Mascara, Algeria, Tel.: 213 6 59319213; E-mail: bachirsb@yahoo.fr
  • Atanasio Pandiella Instituto de Biología Molecular y Celular del Cáncer, CSIC-IBSAL-Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain

DOI:

https://doi.org/10.17179/excli2020-2968

Keywords:

COVID-19, Selenium, SARS-CoV-2

Published

2020-12-07

How to Cite

Benarba, B., & Pandiella, A. (2020). What about incorporating selenium in the therapeutic regimen of SARS-CoV-2?. EXCLI Journal, 19, 1544–1546. https://doi.org/10.17179/excli2020-2968

Issue

Section

Letters to the editor